{"id":"https://openalex.org/W7225006750","doi":"https://doi.org/10.5281/zenodo.23829391","title":"Structure-Based In-Silico Evaluation of Arbutin against the Invasion\u2013 Metastasis Targets MRCK-\u03b2, 14-3-3\u03c3 and Heparanase: Molecular Docking, Protein\u2013Ligand Interaction and ADMET Profiling","display_name":"Structure-Based In-Silico Evaluation of Arbutin against the Invasion\u2013 Metastasis Targets MRCK-\u03b2, 14-3-3\u03c3 and Heparanase: Molecular Docking, Protein\u2013Ligand Interaction and ADMET Profiling","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225006750","doi":"https://doi.org/10.5281/zenodo.23829391"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23829391","doi":"https://doi.org/10.5281/zenodo.23829391","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23829391","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23829391","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5152646909","display_name":"Dr. R. SUNDARARAJAN, Mrs. K. SUGANYA SRI, M.SYED ASHIFA, M.ACHUTHA, S. DIVYA BHARATHI, V.PUJAA, S.SASIKALA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dr. R. SUNDARARAJAN 1, Mr. S.G. RAMAN* 2, BHUVARAGAN.S 3, SYED ARIF AHAMED.S , MOHAMED FAIZAL.N , MOHAMED IMRAN.R","raw_affiliation_strings":["Mohamed Sathak A.J College of Pharmacy, Sholinganallur Chennai , Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mohamed Sathak A.J College of Pharmacy, Sholinganallur Chennai , Tamil Nadu, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5152646909"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83038245,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/arbutin","display_name":"arbutin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/14-3-3-sigma","display_name":"14-3-3 sigma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/heparanase","display_name":"heparanase","score":1.0},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.8669999837875366},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.8309999704360962},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8610000014305115},{"id":"https://openalex.org/keywords/5-fluorouridine","display_name":"5-fluorouridine","score":0.7940000295639038},{"id":"https://openalex.org/keywords/fusicoccin-a","display_name":"fusicoccin A","score":0.796999990940094},{"id":"https://openalex.org/keywords/skin-cancer","display_name":"skin cancer","score":0.39500001072883606},{"id":"https://openalex.org/keywords/protein-ligand-binding-affinity","display_name":"protein-ligand binding affinity","score":0.656000018119812},{"id":"https://openalex.org/keywords/admet-prediction","display_name":"ADMET prediction","score":0.7630000114440918},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.7139999866485596},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.35499998927116394},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.4269999861717224},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2781424683","wikidata":"https://www.wikidata.org/wiki/Q416446","display_name":"Arbutin","level":2,"score":0.9477999806404114},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.720300018787384},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5184999704360962},{"id":"https://openalex.org/C2777478136","wikidata":"https://www.wikidata.org/wiki/Q909646","display_name":"Heparanase","level":4,"score":0.49410000443458557},{"id":"https://openalex.org/C28406088","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Extracellular","level":2,"score":0.45879998803138733},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4047999978065491},{"id":"https://openalex.org/C2777066959","wikidata":"https://www.wikidata.org/wiki/Q869711","display_name":"Cricetulus","level":4,"score":0.37790000438690186},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.37380000948905945},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.3675000071525574},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.35420000553131104},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3402999937534332},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3368000090122223},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.3276999890804291},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.3125999867916107},{"id":"https://openalex.org/C194671627","wikidata":"https://www.wikidata.org/wiki/Q192639","display_name":"Glycoside","level":2,"score":0.31209999322891235},{"id":"https://openalex.org/C2778125326","wikidata":"https://www.wikidata.org/wiki/Q327506","display_name":"Glucosamine","level":2,"score":0.2955000102519989},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.2768000066280365},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.27379998564720154},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.27300000190734863}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23829391","doi":"https://doi.org/10.5281/zenodo.23829391","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23829391","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23829392","doi":"https://doi.org/10.5281/zenodo.23829392","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23829392","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23829391","doi":"https://doi.org/10.5281/zenodo.23829391","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23829391","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7155029074","https://openalex.org/W7136137194","https://openalex.org/W4409667020","https://openalex.org/W4220857569","https://openalex.org/W4417187380","https://openalex.org/W1982794238","https://openalex.org/W4394720288","https://openalex.org/W4400297598","https://openalex.org/W3092920235","https://openalex.org/W4200187293"],"abstract_inverted_index":{"AbstractBackground:":[0],"Arbutin":[1,189,223],"(hydroquinone-O-\u03b2-D-glucopyranoside)":[2],"is":[3,22],"a":[4,9,27,158,176,205,249],"phenolic":[5],"glycoside":[6],"usedwidely":[7],"as":[8],"skin-depigmenting":[10],"agent,":[11],"but":[12],"its":[13],"potential":[14],"to":[15,130,192],"engage":[16],"the":[17,44,81,87,116,148,162,169,182,211,234,246],"protein":[18],"machinery":[19],"of":[20,37,128,248],"tumourinvasion":[21],"undefined.":[23],"We":[24],"evaluated,":[25],"by":[26,85,144],"reproducible":[28],"structure-based":[29],"workflow,":[30],"whetherarbutin":[31],"binds":[32],"three":[33,123,226],"mechanistically":[34],"distinct":[35],"drivers":[36],"cutaneous":[38],"tumour":[39],"invasion":[40,227],"and":[41,49,52,69,95,98,104,112,172,204,245,256],"comparedit":[42],"with":[43,93,102,126,161,196,229],"topical":[45,250],"agent":[46],"5-fluorouracil.Methods:":[47],"\u03b1-":[48],"\u03b2-arbutin,":[50],"5-fluorouridine":[51],"5-fluorouracil":[53,140],"were":[54,91],"docked":[55,76],"(AutoDock":[56],"Vina1.2.7)":[57],"against":[58],"five":[59],"human":[60],"crystal":[61],"structures:":[62],"MRCK-\u03b2":[63,174],"(PDB":[64],"5OTE),":[65],"14-3-3\u03c3":[66,166],"(7OBC,":[67],"7OBX,8RRM)":[68],"heparanase":[70,149,235],"(7PR7).":[71],"Each":[72],"ligand\u2013receptor":[73],"pair":[74],"was":[75,83,190],"in":[77,165,173],"triplicate":[78],"withindependent":[79],"seeds;":[80],"protocol":[82],"validated":[84],"re-docking":[86],"co-crystallised":[88],"ligands.":[89],"Bestposes":[90],"profiled":[92],"PLIP,":[94],"physicochemical,":[96],"drug-likeness":[97],"ADMET":[99],"properties":[100],"werecomputed":[101],"RDKit":[103],"ADMET-AI.Results:":[105],"Re-docking":[106],"reproduced":[107],"BDP-00008900":[108],"(RMSD":[109],"0.54":[110],"\u00c5)":[111],"fusicoccin-A":[113],"(1.34":[114],"\u00c5),validating":[115],"protocol.":[117],"Both":[118],"arbutin":[119],"anomers":[120],"bound":[121],"all":[122,225],"target":[124,143],"classes":[125],"predictedaffinities":[127],"-6.0":[129],"-6.6":[131],"kcal/mol,":[132],"essentially":[133],"invariant":[134],"across":[135],"structurally":[136],"unrelated":[137],"sites,":[138],"andoutscored":[139],"at":[141],"every":[142],"1.0\u20132.0":[145],"kcal/mol.":[146],"In":[147],"catalytic":[150,163,236],"cleft":[151],"\u03b1-arbutin":[152],"formed":[153],"ten":[154],"hydrogen":[155],"bonds,":[156],"including":[157],"direct":[159],"contact":[160],"nucleophileGlu343;":[164],"it":[167],"occupied":[168],"phosphoserine-coordinating":[170],"sub-site;":[171],"itadopted":[175],"canonical":[177],"type-I":[178],"kinase":[179],"orientation,":[180],"although":[181],"designed":[183],"inhibitor":[184],"BDP-00008900scored":[185],"2.5":[186],"kcal/mol":[187],"stronger.":[188],"predicted":[191],"be":[193],"highly":[194],"polar":[195],"low":[197],"passivepermeability,":[198],"no":[199],"P-glycoprotein":[200],"or":[201],"cytochrome-P450":[202],"liability,":[203],"markedly":[206],"more":[207],"favourabletoxicity":[208],"profile":[209],"than":[210],"fluoropyrimidines":[212],"(predicted":[213],"DILI":[214],"0.14":[215],"vs":[216,221],"0.81;":[217],"LD\u2085\u2080":[218],"\u2248":[219],"2,700":[220],"436mg/kg).Conclusion:":[222],"engages":[224],"targets":[228],"chemically":[230],"specific":[231],"interactions,most":[232],"compellingly":[233],"cleft,":[237],"whose":[238],"extracellular":[239],"localisation":[240],"matchesarbutin\u2019s":[241],"poorly":[242],"permeable":[243],"physicochemistry":[244],"requirements":[247],"agent.":[251],"Thesecomputational":[252],"predictions":[253],"warrant":[254],"biochemical":[255],"cellular":[257],"validation.":[258]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2026-11-01T00:00:00"}